← 產業報告目錄

Spinal Needles Market Research Report by Type (Atraumatic Needles, Directional Spinal Needles, Pencil-point Needles), by Application (Therapeutic, Diagnostic), by End User (Hospitals & Clinics, Diagnostic Centers, Research Laboratories, Specialty Centers), and by Region (Americas, Europe, Asia Pacific, Middle East and Africa) Forecast till 2027

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2025-08-17頁數 114報告編號 MRFRMED0709HCR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Spinal Needles Market Research Report by Type (Atraumatic Needles, Directional Spinal Needles, Pencil-point Needles), by Application (Therapeutic, Diagnostic), by End User (Hospitals & Clinics, Diagnostic Centers, Research Laboratories, Specialty Centers), and by Region (Americas, Europe, Asia Pacific, Middle East and Africa) Forecast till 2027 Market Overview The global spinal needles market is projected to reach USD 356.74 million by 2027, growing at a CAGR of 7.48% from 2021 to 2027. Spinal needles are specialized medical instruments used to deliver anesthesia or collect cerebrospinal fluid from the spinal canal. They are designed with a fine, hollow structure that allows precise access to the subarachnoid space while minimizing tissue damage. These needles play a vital role in procedures such as spinal anesthesia, diagnostic lumbar punctures, and intrathecal drug administration. The global spinal needles market is greatly influenced by the increasing use of spinal needles in spine surgeries such as percutaneous vertebroplasty, kyphoplasty, spinal fusion, and interbody fusion. The major cause for the use of pencil-point needles for spinal anesthesia is the clinical advantages that they offer, and this trend continues to support the market demand. Ongoing clinical trials, technological developments, and government-supported R&D activities are the main factors behind the growing preference for minimally invasive surgical methods. Key Company Development Medtronic plc has been able to expand its leadership in various types of spinal surgery. Among other things, in November of 2020, it bought the French company Medicrea, an AI leader in spinal surgery planning, implants, and robotic-assisted procedures. Medtronic had already made an important investment in the field of spinal surgery with the acquisition of Titan Spine, an American company specializing in spinal implants and surface technology, in June 2019. These acquisitions are milestones in Medtronic’s plan to bring enhanced precision, technology, and, most importantly, patient outcomes to the global spinal surgery market. Major Players Key players in the global spinal needles market are Stryker, Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic Plc, Smiths Medical, Becton, Dickinson, and Company, EXELINT International, Co., Argon Medical, Myco Medical, and Cook Medical. Report Attribute Details • Market Size 2020: USD 216.42 Million • Market Size 2027: USD 356.74 Million • CAGR (2021-2027): 7.48% • Base Year: 2020 • Market Forecast Period: 2021-2027 Market Segmentations • By Type: Atraumatic Needles - 7.33%, Directional Spinal Needles - 6.52%. • By Application: Therapeutic - 7.87%, Diagnostic - 6.61%. • By End User: Hospitals & Clinics - 8.39%, Diagnostic Centers - 7.54%. Regional Insights The Americas are the leading cause of the global market for spinal needles, as the disorders of the spinal cord and neurological diseases are widespread in this region and require both diagnostic and therapeutic interventions. At USD 20.54 million, Latin America reflects growing opportunities in underserved healthcare markets. Generating USD 67.54 million in 2020, North America dominates thanks to established players and continuous adoption of minimally invasive solutions. Europe is the second-largest market for spinal needles. The continent, supported by its rapidly aging population and the increase of neurodegenerative disorders, depends to a large extent on government initiatives, healthcare reforms, and the research ecosystem that is funded by programs such as ERA-NET NEURON in the region. The European market reached USD 42.53 million in Western Europe and USD 14.68 million in Eastern Europe, highlighting regional disparities in adoption and investment. Asia-Pacific is the region that develops the fastest, with the healthcare sector that makes a substantial investment, the infrastructure for clinical trials is being developed very rapidly, and supplies are plentiful. The research on spinal procedures is largely carried out by institutions such as universities and hospitals in countries like Pakistan, Korea, Taiwan, and Nepal. Asia-Pacific markets, China (USD 9.98 million), Japan (USD 7.09 million), and India (USD 8.25 million), are evolving rapidly with expanding clinical trials and rising healthcare spending. The Middle East & Africa represent an emerging but relatively restricted market due to limited affordability and uneven healthcare access. However, rising healthcare investments in the Middle East and the establishment of diagnostic centers in Africa are boosting growth prospects. Hospitals like HJ Hospitals in DR Congo, equipped with advanced diagnostic facilities, are expanding access to spinal procedures.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 13 2 MARKET INTRODUCTION 14 2.1 SCOPE OF THE STUDY 14 2.2 RESEARCH OBJECTIVE 14 2.3 MARKET STRUCTURE 14 2.4 ASSUMPTIONS & LIMITATIONS 15 3 RESEARCH METHODOLOGY 16 3.1 DATA MINING 16 3.2 SECONDARY RESEARCH 17 3.3 PRIMARY RESEARCH 18 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19 3.5 FORECASTING TECHNIQUES 20 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21 3.6.1 BOTTOM-UP APPROACH 22 3.6.2 TOP-DOWN APPROACH 22 3.7 DATA TRIANGULATION 23 3.8 VALIDATION 23 4 MARKET DYNAMICS 24 4.1 OVERVIEW 24 4.2 DRIVERS 25 4.2.1 INCREASING PREVALENCE OF SPINAL STENOSIS AND NEUROLOGICAL DISORDERS 25 4.2.2 RISING GERIATRIC POPULATION PRONE TO SPINAL DISORDERS 25 4.2.3 INCREASING APPLICATION OF SPINAL NEEDLES FOR SPINE SURGERIES 25 4.3 RESTRAINTS 26 4.3.1 SIDE EFFECTS AND COMPLICATIONS ASSOCIATED WITH SPINE SURGERY 26 4.3.2 STRINGENT GOVERNMENT REGULATIONS 26 4.4 OPPORTUNITIES 27 4.4.1 INCREASING NUMBER OF COLLABORATIONS, ACQUISITIONS, AND PRODUCT LAUNCHES 27 5 MARKET FACTOR ANALYSIS 28 5.1 VALUE CHAIN ANALYSIS 28 5.1.1 R&D AND DESIGNING 29 5.1.2 MANUFACTURING 29 5.1.3 DISTRIBUTION, MARKETING, & SALES 29 5.1.4 POST-SALES MONITORING 29 5.2 PORTER'S FIVE FORCES MODEL 30 5.2.1 THREAT OF NEW ENTRANTS 30 5.2.2 BARGAINING POWER OF SUPPLIERS 31 5.2.3 THREAT OF SUBSTITUTES 31 5.2.4 BARGAINING POWER OF BUYERS 31 5.2.5 INTENSITY OF RIVALRY 31 5.3 COVID-19 IMPACT ANALYSIS 32 5.3.1 IMPACT ON SPINAL SURGERY 32 5.3.2 IMPACT ON SPINE SURGEONS 32 5.3.3 IMPACT ON CLINICAL TRIALS 32 6 GLOAL SPINAL NEEDLES MARKET, BY TYPE 33 6.1 INTRODUCTION 33 6.2 ATRAUMATIC NEEDLES 34 6.3 DIRECTIONAL SPINAL NEEDLES 35 6.4 PENCIL-POINT NEEDLES 36 7 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION 37 7.1 INTRODUCTION 37 7.2 THERAPEUTIC 38 7.3 DIAGNOSTIC 39 8 SPINAL NEEDLES MARKET, BY END USER 40 8.1 OVERVIEW 40 8.2 HOSPITALS & CLINICS 41 8.3 DIAGNOSTIC CENTERS 42 8.4 RESEARCH LABORATORIES 43 8.5 SPECIALTY CENTERS 44 9 GLOBAL SPINAL NEEDLES MARKET, BY REGION 45 9.1 OVERVIEW 45 9.2 AMERICAS 47 9.2.1 NORTH AMERICA 49 9.2.1.1 US 50 9.2.1.2 CANADA 51 9.2.2 LATIN AMERICA 52 9.3 EUROPE 54 9.3.1 WESTERN EUROPE 56 9.3.1.1 GERMANY 57 9.3.1.2 FRANCE 58 9.3.1.3 UK 59 9.3.1.4 ITALY 60 9.3.1.5 SPAIN 61 9.3.1.6 REST OF WESTERN EUROPE 62 9.3.2 EASTERN EUROPE 63 9.4 ASIA PACIFIC 65 9.4.1 CHINA 67 9.4.2 INDIA 68 9.4.3 JAPAN 69 9.4.4 SOUTH KOREA 70 9.4.5 AUSTRALIA 71 9.4.6 REST OF ASIA PACIFIC 72 9.5 MIDDLE EAST & AFRICA 73 9.5.1 MIDDLE EAST 75 9.5.2 AFRICA 76 10 COMPETITIVE LANDSCAPE 77 10.1 OVERVIEW 77 10.2 COMPETITIVE BENCHMARKING 78 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL SPINAL NEEDLES MARKET 79 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL SPINAL NEEDLES MARKET 80 10.5 KEY DEVELOPMENT ANALYSIS 80 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 81 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL 81 10.6.2 MERGER/ACQUISITION 81 10.6.3 EXPANSION/INVESTMENT 82 10.7 FINANCIAL MATRIX 82 10.7.1 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020 82 10.7.2 R&D EXPENDITURE (USD MILLION), 2020 83 11 COMPANY PROFILES 84 11.1 STRYKER CORPORATION 84 11.1.1 COMPANY OVERVIEW 84 11.1.2 FINANCIAL OVERVIEW 84 11.1.3 PRODUCTS OFFERED 85 11.1.4 KEY DEVELOPMENTS 85 11.1.5 SWOT ANALYSIS 86 11.1.6 KEY STRATEGIES 86 11.2 BOSTON SCIENTIFIC CORPORATION 87 11.2.1 COMPANY OVERVIEW 87 11.2.2 FINANCIAL OVERVIEW 87 11.2.3 PRODUCTS/SERVICES OFFERED 88 11.2.4 KEY DEVELOPMENTS 88 11.2.5 SWOT ANALYSIS 89 11.2.6 KEY STRATEGIES 89 11.3 B. BRAUN MELSUNGEN AG 90 11.3.1 COMPANY OVERVIEW 90 11.3.2 FINANCIAL OVERVIEW 91 11.3.3 PRODUCTS/SERVICES OFFERED 91 11.3.4 KEY DEVELOPMENTS 92 11.3.5 SWOT ANALYSIS 93 11.3.6 KEY STRATEGIES 93 11.4 MEDTRONIC PLC 94 11.4.1 COMPANY OVERVIEW 94 11.4.2 FINANCIAL OVERVIEW 95 11.4.3 PRODUCTS/SERVICES OFFERED 95 11.4.4 KEY DEVELOPMENTS 96 11.4.5 SWOT ANALYSIS 96 11.4.6 KEY STRATEGIES 96 11.5 SMITHS MEDICAL 97 11.5.1 COMPANY OVERVIEW 97 11.5.2 FINANCIAL OVERVIEW 97 11.5.3 PRODUCTS/SERVICES OFFERED 98 11.5.4 KEY DEVELOPMENTS 99 11.5.5 SWOT ANALYSIS 100 11.5.6 KEY STRATEGIES 100 11.6 BECTON, DICKINSON, AND COMPANY 101 11.6.1 COMPANY OVERVIEW 101 11.6.2 FINANCIAL OVERVIEW 102 11.6.3 PRODUCTS OFFERED 103 11.6.4 KEY DEVELOPMENTS 103 11.6.5 SWOT ANALYSIS 104 11.6.6 KEY STRATEGIES 104 11.7 EXELINT INTERNATIONAL, CO. 105 11.7.1 COMPANY OVERVIEW 105 11.7.2 FINANCIAL OVERVIEW 105 11.7.3 PRODUCTS OFFERED 105 11.7.4 KEY DEVELOPMENTS 105 11.7.5 SWOT ANALYSIS 106 11.7.6 KEY STRATEGIES 106 11.8 ARGON MEDICAL 107 11.8.1 COMPANY OVERVIEW 107 11.8.2 FINANCIAL OVERVIEW 107 11.8.3 PRODUCTS OFFERED 107 11.8.4 KEY DEVELOPMENTS 107 11.8.5 SWOT ANALYSIS 108 11.8.6 KEY STRATEGIES 108 11.9 MYCO MEDICAL 109 11.9.1 COMPANY OVERVIEW 109 11.9.2 FINANCIAL OVERVIEW 109 11.9.3 PRODUCTS OFFERED 109 11.9.4 KEY DEVELOPMENTS 109 11.9.5 SWOT ANALYSIS 110 11.9.6 KEY STRATEGIES 110 11.10 COOK MEDICAL 111 11.10.1 COMPANY OVERVIEW 111 11.10.2 FINANCIAL OVERVIEW 111 11.10.3 PRODUCTS OFFERED 111 11.10.4 KEY DEVELOPMENTS 111 11.10.5 SWOT ANALYSIS 112 11.10.6 KEY STRATEGIES 112 12 APPENDIX 113 12.1 REFERENCES 113 12.2 RELATED REPORTS 113
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 15 TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18 TABLE 3 GLOBAL: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 33 TABLE 4 GLOBAL: SPINAL NEEDLES MARKET, FOR ATRAUMATIC NEEDLES, BY REGIONS, 2018–2027 (USD MILLION) 34 TABLE 5 GLOBAL: SPINAL NEEDLES MARKET, FOR DIRECTIONAL SPINAL NEEDLES, BY REGIONS, 2018–2027 (USD MILLION) 35 TABLE 6 GLOBAL: SPINAL NEEDLES MARKET, FOR PENCIL-POINT NEEDLES, BY REGIONS, 2018–2027 (USD MILLION) 36 TABLE 7 GLOBAL: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 37 TABLE 8 GLOBAL: SPINAL NEEDLES MARKET, FOR THERAPEUTIC, BY REGIONS, 2018–2027 (USD MILLION) 38 TABLE 9 GLOBAL: SPINAL NEEDLES MARKET, FOR DIAGNOSTIC, BY REGIONS, 2018–2027 (USD MILLION) 39 TABLE 10 GLOBAL: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 40 TABLE 11 GLOBAL: SPINAL NEEDLES MARKET, FOR HOSPITALS & CLINICS, BY REGIONS, 2018–2027 (USD MILLION) 41 TABLE 12 GLOBAL: SPINAL NEEDLES MARKET, FOR DIAGNOSTICS CENTERS, BY REGIONS, 2018–2027 (USD MILLION) 42 TABLE 13 GLOBAL: SPINAL NEEDLES MARKET, FOR RESEARCH LABORTORIES, BY REGIONS, 2018–2027 (USD MILLION) 43 TABLE 14 GLOBAL: SPINAL NEEDLES MARKET, FOR SPECIALITY CENTERS, BY REGIONS, 2018–2027 (USD MILLION) 44 TABLE 15 GLOBAL: SPINAL NEEDLES MARKET, BY REGION, 2018–2027 (USD MILLION) 45 TABLE 16 AMERICAS: SPINAL NEEDLES MARKET, BY REGION, 2018–2027 (USD MILLION) 47 TABLE 17 AMERICAS: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 48 TABLE 18 AMERICAS: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 48 TABLE 19 AMERICAS: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 48 TABLE 20 NORTH AMERICA: SPINAL NEEDLES MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 49 TABLE 21 NORTH AMERICA: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 49 TABLE 22 NORTH AMERICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 50 TABLE 23 NORTH AMERICA: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 50 TABLE 24 US: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 50 TABLE 25 US: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 51 TABLE 26 US: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 51 TABLE 27 CANADA: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 51 TABLE 28 CANADA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 52 TABLE 29 CANADA: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 52 TABLE 30 LATIN AMERICA: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 52 TABLE 31 LATIN AMERICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 53 TABLE 32 LATIN AMERICA: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 53 TABLE 33 EUROPE: SPINAL NEEDLES MARKET, BY REGION, 2018–2027 (USD MILLION) 54 TABLE 34 EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 55 TABLE 35 EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 55 TABLE 36 EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 55 TABLE 37 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 56 TABLE 38 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 56 TABLE 39 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 57 TABLE 40 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 57 TABLE 41 GERMANY: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 57 TABLE 42 GERMANY: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 58 TABLE 43 GERMANY: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 58 TABLE 44 FRANCE: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 58 TABLE 45 FRANCE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 59 TABLE 46 FRANCE: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 59 TABLE 47 UK: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 59 TABLE 48 UK: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 60 TABLE 49 UK: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 60 TABLE 50 ITALY: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 60 TABLE 51 ITALY: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 61 TABLE 52 ITALY: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 61 TABLE 53 SPAIN: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 61 TABLE 54 SPAIN: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 62 TABLE 55 SPAIN: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 62 TABLE 56 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 62 TABLE 57 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 63 TABLE 58 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 63 TABLE 59 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 63 TABLE 60 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 64 TABLE 61 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 64 TABLE 62 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 65 TABLE 63 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 66 TABLE 64 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 66 TABLE 65 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 66 TABLE 66 CHINA: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 67 TABLE 67 CHINA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 67 TABLE 68 CHINA: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 67 TABLE 69 INDIA: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 68 TABLE 70 INDIA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 68 TABLE 71 INDIA: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 68 TABLE 72 JAPAN: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 69 TABLE 73 JAPAN: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 69 TABLE 74 JAPAN: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 69 TABLE 75 SOUTH KOREA: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 70 TABLE 76 SOUTH KOREA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 70 TABLE 77 SOUTH KOREA: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 70 TABLE 78 AUSTRALIA: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 71 TABLE 79 AUSTRALIA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 71 TABLE 80 AUSTRALIA: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 71 TABLE 81 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 72 TABLE 82 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 72 TABLE 83 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 72 TABLE 84 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY REGION, 2018–2027 (USD MILLION) 73 TABLE 85 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 74 TABLE 86 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 74 TABLE 87 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 74 TABLE 88 MIDDLE EAST: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 75 TABLE 89 MIDDLE EAST: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 75 TABLE 90 MIDDLE EAST: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 75 TABLE 91 AFRICA: SPINAL NEEDLES MARKET, BY TYPE, 2018–2027 (USD MILLION) 76 TABLE 92 AFRICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 76 TABLE 93 AFRICA: SPINAL NEEDLES MARKET, BY END USER, 2018–2027 (USD MILLION) 76 TABLE 94 MAJOR PLAYERS IN THE GLOBAL SPINAL NEEDLES MARKET 77 TABLE 95 MOST ACTIVE PLAYER IN THE GLOBAL SPINAL NEEDLES MARKET 80 TABLE 96 PRODUCT LAUNCH/PRODUCT APPROVAL 81 TABLE 97 MERGER/ACQUISITION 81 TABLE 98 EXPANSION/INVESTMENT 82 TABLE 99 STRYKER CORPORATION: PRODUCTS/SERVICES OFFERED 85 TABLE 100 STRYKER CORPORATION: KEY DEVELOPMENTS 85 TABLE 101 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED 88 TABLE 102 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS 88 TABLE 103 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED 91 TABLE 104 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS 92 TABLE 105 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED 95 TABLE 106 MEDTRONIC PLC: KEY DEVELOPMENTS 96 TABLE 107 SMITHS MEDICAL: PRODUCTS/SERVICES OFFERED 98 TABLE 108 SMITHS MEDICAL: KEY DEVELOPMENTS 99 TABLE 109 BECTON, DICKINSON, AND COMPANY: PRODUCTS/SERVICES OFFERED 103 TABLE 110 BECTON, DICKINSON, AND COMPANY: KEY DEVELOPMENTS 103 TABLE 111 EXELINT INTERNATIONAL, CO.: PRODUCTS/SERVICES OFFERED 105 TABLE 112 ARGON MEDICAL: PRODUCTS/SERVICES OFFERED 107 TABLE 113 ARGON MEDICAL: KEY DEVELOPMENTS 107 TABLE 114 MYCO MEDICAL: PRODUCTS/SERVICES OFFERED 109 TABLE 115 COOK MEDICAL: PRODUCTS/SERVICES OFFERED 111 TABLE 116 COOK MEDICAL: KEY DEVELOPMENTS 111 LIST OF FIGURES FIGURE 1 MARKET SYNOPSIS 13 FIGURE 2 GLOBAL SPINAL NEEDLES MARKET 14 FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 21 FIGURE 4 MARKET DYNAMICS: GLOBAL SPINAL NEEDLES MARKET 24 FIGURE 5 DRIVERS: IMPACT ANALYSIS 26 FIGURE 6 RESTRAINTS: IMPACT ANALYSIS 27 FIGURE 7 VALUE CHAIN ANALYSIS OF GLOBAL SPINAL NEEDLES MARKET 28 FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL SPINAL NEEDLES MARKET 30 FIGURE 9 GLOBAL SPINAL NEEDLES MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 33 FIGURE 10 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 37 FIGURE 11 GLOBAL SPINAL NEEDLES MARKET, BY END USER, 2020 & 2027 (USD MILLION) 40 FIGURE 12 GLOBAL: SPINAL NEEDLES MARKET, BY REGION 2020 & 2027 (USD MILLION) 45 FIGURE 13 GLOBAL: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020 46 FIGURE 14 AMERICAS: SPINAL NEEDLES MARKET SHARE (%), BY REGION 2020 47 FIGURE 15 NORTH AMERICA: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY 2020 49 FIGURE 16 EUROPE: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020 54 FIGURE 17 WESTERN EUROPE: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY, 2020 56 FIGURE 18 ASIA PACIFIC: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY 2020 65 FIGURE 19 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020 73 FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS 78 FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL SPINAL NEEDLES MARKET 79 FIGURE 22 GLOBAL SPINAL NEEDLES MARKET: COMPETITIVE LANDSCAPE 80 FIGURE 23 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020 82 FIGURE 24 R&D EXPENDITURE (USD MILLION), 2020 83 FIGURE 25 STRYKER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 84 FIGURE 26 STRYKER CORPORATION: SWOT ANALYSIS 86 FIGURE 27 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 87 FIGURE 28 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 89 FIGURE 29 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT 91 FIGURE 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 93 FIGURE 31 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 95 FIGURE 32 B MEDTRONIC PLC: SWOT ANALYSIS 96 FIGURE 33 SMITHS GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT 97 FIGURE 34 SMITHS MEDICAL: SWOT ANALYSIS 100 FIGURE 35 BECTON, DICKINSON, AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 102 FIGURE 36 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS 104 FIGURE 37 EXELINT INTERNATIONAL, CO.: SWOT ANALYSIS 106 FIGURE 38 ARGON MEDICAL: SWOT ANALYSIS 108 FIGURE 39 MYCO MEDICAL: SWOT ANALYSIS 110 FIGURE 40 COOK MEDICAL: SWOT ANALYSIS 112

提及公司

StrykerBoston Scientific CorporationB. Braun Melsungen AGMedtronic PlcSmiths MedicalBectonDickinsonand CompanyEXELINT InternationalCo.Argon MedicalMyco Medicaland Cook Medical.

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 Market Research Future 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們